Iron absorption in patients on regular dialysis therapy

Area of Science:

• Nephrology
• Hematology
• Nutritional Science

Background:

• Chronic renal failure (CRF) often leads to anemia due to depressed erythropoietic activity.
• Iron deficiency is a common complication in patients with CRF undergoing regular hemodialysis.
• Understanding iron absorption in this population is crucial for effective management.

Purpose of the Study:

• To investigate iron absorption rates in patients with CRF on hemodialysis.
• To determine if erythropoietic activity affects iron absorption.
• To assess the relationship between iron absorption and iron stores (serum ferritin).

Main Methods:

• Conducted hematological, ferrokinetic, and iron absorption measurements.
• Administered both small (3 mg) and large (50 mg) doses of ferrous iron.
• Correlated iron absorption rates with serum ferritin concentrations.

Main Results:

• No significant impairment in iron absorption was observed despite depressed erythropoiesis.
• A significant inverse correlation was found between iron absorption rate and serum ferritin levels.
• This absorption-ferritin relationship mirrored findings in individuals with normal renal function.

Conclusions:

• The absorptive mechanism for iron appears normal in patients with CRF on hemodialysis.
• Oral iron therapy is a viable and effective strategy for managing iron deficiency in this patient group.
• CRF patients undergoing hemodialysis can be adequately treated for iron deficiency with oral iron supplementation.